Desjardins Global Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
$88.8K Buy
464
+6
+1% +$1.15K 0.01% 483
2023
Q3
$81.1K Buy
+458
New +$81.1K 0.01% 492